Madison, WI, United States of America

Amy Klimowicz

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2003-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amy Klimowicz. Retrieved from https://idiyas.com/inventor/amy-klimowicz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2003-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Amy Klimowicz: Inventor in Biotechnology.

Introduction

Amy Klimowicz is an inventor associated with Madison, Wisconsin, and the Wisconsin Alumni Research Foundation. Her work includes patenting approaches to reduce enterotoxin production in bacteria, with potential applications in biocontrol.

Latest Patents

Klimowicz is credited with 4 patents. Among the listed patent titles are “Construction of a Quadruple Enterotoxin-Deficient Mutant of Bacillus thuringiensis” and a related listing, “Construction of a Quadruple Enterotoxin-Deficient Mutant.” The disclosed mutants are designed not to produce specified HBL and NHE enterotoxins, which are associated with food-borne illness. The patent descriptions discuss methods for creating and using these mutants, including their potential use as biocontrol agents.

Career Highlights

Klimowicz’s patent work is connected with the Wisconsin Alumni Research Foundation, an organization that supports research and innovation. The listed inventions focus on modifying bacterial strains to address concerns related to enterotoxin production.

Collaborations

Her listed collaborators include Jo E. Handelsman and Changhui Guan. Their names appear alongside work concerning enterotoxin-deficient bacterial mutants.

Conclusion

Amy Klimowicz’s patent portfolio reflects biotechnology research aimed at developing enterotoxin-deficient bacterial strains and exploring their use as biocontrol agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…